It is our longterm goal to understand the influence of apoptotic cells and their clearance mechanisms in atherogenesis. Towards this overall goal, using a differential proteomics screen, we have identified an apoptotic cell engulfment protein ligand, termed annexin-1. This protein is rapidly exported to the external leaflet of plasma membrane during apoptosis, and this protein is required for efficient engulfment of apoptotic cells by the macrophages. We also demonstrate in our recent data that crossing annexin-1 null animals with ApoE animals results in accelerated atherosclerosis. In this proposal, we will test our central premise that underlying mechanisms of apoptosis cell engulfment influence atherogenesis in collaboration with the members of the PPG. We propose to examine the functional role of annexin-1 in contributing apoptotic cell egulfment in the vessel wall, and explore the primary cell type that is affected in the annexin-1 null mice. We will test the consequences of accelerated macrophage apoptotosis together with project 2. We will investigate the mechanism of inefficient engulfment of apoptotic cells by bone-marrow-derived macrophages together with project 1, and 2. We will examine the macrophage cytokine expressing in vitro, in mouse models of atherosclerosis, and in human lesions together with projects 1, 2, and 4. The results from this investigation are anticipated to illuminate new mechanistic information on a poorly-understood process of apoptotic cell engulfment in atherosclerosis.
This study will investigate apoptotic cell engulfment process as a critical influencing factor that determine the outcome atherosclerosis. Thus, information forthcoming from this study may have a significant impact in understanding and ultimately treating human atherosclerosis.
|Gerber, Claire; Harel, Miriam; Lynch, Miranda L et al. (2016) Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study. J Pediatr Urol 12:120.e1-7|
|Harel, Miriam; Ferrer, Fernando A; Shapiro, Linda H et al. (2016) Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma. Urol Oncol 34:103-15|
|Galvani, Sylvain; Sanson, Marie; Blaho, Victoria A et al. (2015) HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal 8:ra79|
|Ghosh, Mallika; Subramani, Jaganathan; Rahman, M Mamunur et al. (2015) CD13 restricts TLR4 endocytic signal transduction in inflammation. J Immunol 194:4466-76|
|Blaho, Victoria A; Galvani, Sylvain; Engelbrecht, Eric et al. (2015) HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature 523:342-6|
|Ghosh, Mallika; Gerber, Claire; Rahman, M Mamunur et al. (2014) Molecular mechanisms regulating CD13-mediated adhesion. Immunology 142:636-47|
|Rahman, M Mamunur; Ghosh, Mallika; Subramani, Jaganathan et al. (2014) CD13 regulates anchorage and differentiation of the skeletal muscle satellite stem cell population in ischemic injury. Stem Cells 32:1564-77|
|Blaho, Victoria A; Hla, Timothy (2014) An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res 55:1596-608|
|Mendelson, Karen; Zygmunt, Tomasz; Torres-Vázquez, Jesús et al. (2013) Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning. J Biol Chem 288:2143-56|
|Xiong, Yuquan; Lee, Hyuek Jong; Mariko, Boubacar et al. (2013) Sphingosine kinases are not required for inflammatory responses in macrophages. J Biol Chem 288:32563-73|
Showing the most recent 10 out of 90 publications